Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future

Runxing Lin1, Ziyu Huang1, Yu Liu1

  • 1Joint Key Laboratory of the Ministry of Education, Institute of Applied Physics and Materials Engineering, University of Macau, Avenida da Universidade, Taipa 999078, Macau.

Biosensors
|March 26, 2025
PubMed

Insights

Personalized cardiovascular drug therapy addresses individual variability in treating heart disease. This review explores dynamic monitoring and data analysis strategies for tailored treatments.

Area of Science:

  • Cardiology
  • Pharmacogenomics
  • Biomedical Engineering

Background:

  • Cardiovascular diseases (CVDs) pose significant global health challenges.
  • Individual variability in patient response complicates effective CVD treatment.
  • Personalized medicine offers a promising approach to optimize cardiovascular drug therapy.

Purpose of the Study:

  • To review strategies for personalized cardiovascular drug therapy.
  • To examine dynamic monitoring and multidimensional data analysis techniques.
  • To identify current challenges and future research directions in the field.

Main Methods:

  • Systematic literature review of personalized cardiovascular drug therapy.
  • Analysis of traditional dynamic monitoring technologies.
  • Evaluation of multidimensional data integration and analysis approaches.

Main Results:

  • Dynamic monitoring and data integration are key to personalized CVD treatment.
  • Individual differences necessitate tailored monitoring and analysis strategies.
  • Current research faces challenges in implementing these personalized approaches.

Conclusions:

  • Personalized cardiovascular drug therapy requires advanced monitoring and data analysis.
  • Future research should focus on overcoming implementation challenges.
  • Tailoring treatments to individual variability is crucial for improving CVD outcomes.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
740
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
205
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
37
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
576
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
248